- 1. 17ad
- [Mandibular left third molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553651) =Medical Device =Artificial dentition;
| - 51. adapter protein
- [ ] (UMLS (CSP) C0599697) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 2. 18ad
- [Mandibular left second molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553654) =Medical Device =Artificial dentition;
| - 52. Adaptor Protein
- [A class of signaling pathway proteins that function to mediate the coupling of multiple cell surface receptors to downstream signaling pathways in the regulation of various cellular functions. (from Oncogene 2001;20:6315-21) ( NCI )] (UMLS (NCI) C1135629) Adaptor Signaling Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 3. 19ad
- [Mandibular left first molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553657) =Medical Device =Artificial dentition;
| - 53. Adaptor Protein Containing PH and SH2 Domains
- [Encoded by human APS Gene, 85 kD APS Protein appears to be found in spleen, prostate, testis, uterus, small intestine, skeletal muscle, and peripheral blood leukocytes. The 632-amino acid adaptor protein contains a PH domain, a SH2 domain, and a C-terminal tyrosine phosphorylation site. APS is structurally similar to the T-cell adaptor protein/signal transducer LNK and is tyrosine-phosphorylated after BCR cross-linking. APS associates with SHC regardless of BCR stimulation and with GRB2 after BCR stimulation. (OMIM and NCI) ( NCI )] (UMLS (NCI) C1449108) Adaptor Protein with Pleckstrin Homology and SRC Homology 2 Domains;
APS;
APS Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 4. 30ad
- [Mandibular right first molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553670) =Medical Device =Artificial dentition;
| - 54. Adaptor Protein Gene
- [A class of genes that encode signaling pathway proteins that function to mediate the coupling of multiple cell surface receptors to downstream signaling pathways in the regulation of various cellular functions. (from Oncogene 2001;20:6315-21) ( NCI )] (UMLS (NCI) C1332163) Adaptor Signaling Protein Gene;
=Gene or Genome ;
|
- 5. 31ad
- [Mandibular right second molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553673) =Medical Device =Artificial dentition;
| - 55. Adaptor Protein with Pleckstrin Homology and SRC Homology 2 Domains Gene
- [This gene is involved in signal transduction and plays a role in insulin-mediated glucose uptake. ( NCI )] (UMLS (NCI) C1332107) APS;
SH2B Adaptor Protein 2 Gene;
SH2B2;
SH2B2 Gene =Gene or Genome ;
|
- 6. 32ad
- [Mandibular right third molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553676) =Medical Device =Artificial dentition;
| - 56. ADCC
- [Antibody-dependent target cell killing by a killer cell. An antibody is directed to the target by antigen-binding arms and anchors to the killer cell by an Fc receptor. Antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IgG whose Fc portion is intact. The effector "killer" cell possesses Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ( NCI )] (UMLS (CSP) C0003272) =Cell Function ;
|
- 7. 6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid
- [A topical retinoid-like compound, chemically similar to vitamin A. Although the exact mechanism of action is unknown, adapalene binds to specific retinoic acid receptors in the nucleus, leading to specific gene expression. This agent stimulates skin growth through modulation of cellular differentiation, inflammatory processes and keratinization of follicular epithelial cells. Adapalene may increase dermal sensitivity to ultraviolet radiation. (NCI04) ( NCI )] (UMLS (NCI) C0165631) =Organic Chemical; Pharmacologic Substance =naphthalene;
[DE752] ANTIACNE AGENTS, TOPICAL =ADAPALENE 0.1 % | - 57. ADCC Assay
- [An assay based on Antibody-Dependent Cellular Cytotoxicity which involves the killing of a target cell by a killer cell by means of an antibody directed to the target by the antigen-binding arms and anchored to the killer cell via an Fc receptor. ( NCI )] (UMLS (NCI) C0201624) =Laboratory Procedure
|
- 8. A Disintegrin and Metalloprotease with Thrombospondin Motifs-1
- [A disintegrin and metalloproteinase with thrombospondin motifs-1 (ADAMTS-1), encoded by the ADAMTS1 gene is a member of the ADAMTS protein family. It cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. It has anti-angiogenic activity and inhibits endothelial cell proliferation. ADAMTS1 may be associated with various inflammatory processes as well as development of cancer cachexia. It is likely to be necessary for normal growth, fertility, and organ morphology and function. ADAMTS1 is secreted and associated with the extracellular matrix. The Spacer Domain and the TSP Type-1 Domains are important for a tight interaction with the extracellular matrix. ADAMTS1 is expressed as a 110-kD protein, an 85-kD protein after cleavage at the subtilisin site, or as a 67-kD protein, which is most abundant, generated by an additional processing event. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C1307941) A Disintegrin And Metalloproteinase With Thrombospondin Motifs 1;
ADAMTS1;
ADAM-TS1;
METH-1 =Amino Acid, Peptide, or Protein; Enzyme | - 58. ADCOMP
- (UMLS (NCI) C0279504) =Therapeutic or Preventive Procedure
|
- 9. A Disintegrin and Metalloprotease with Thrombospondin Motifs-9
- [A disintegrin and metalloproteinase with thrombospondin motifs-9 (ADAMTS9), encoded by the ADAMTS9 gene, is a member of the ADAMTS protein family. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. This enzyme contains four C-terminal TS motifs. The spacer domain and the TSP Type-1 domains are important for a tight interaction with the extracellular matrix. The precursor is cleaved by a furin endopeptidase. Two isoforms, a long form and a short form, may be produced by alternative splicing. ADAMTS9 is secreted and associated with the extracellular matrix. It is highly expressed in all fetal tissues and expressed slightly in adult ovary, pancreas, heart, kidney, lung, placenta, spinal cord and brain. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C1257533) A Disintegrin and Metalloproteinase with Thrombospondin Motifs-9;
ADAMTS9;
ADAM-TS9 =Amino Acid, Peptide, or Protein; Enzyme ;
| - 59. ADCY9
- [This gene is involved in nucleotide metabolism and signal transduction. ( NCI )] (UMLS (NCI) C1332025) ADCY9 Gene;
Adenylate Cyclase 9 Gene;
=Gene or Genome ;
|
- 10. A Disintegrin and Metalloproteinase Domain 11 Gene
- [This gene plays a role in cell-cell and cell-matrix interactions. ( NCI )] (UMLS (NCI) C1332015) ADAM11;
ADAM11 Gene;
=Gene or Genome ;
| - 60. ADCY9
- [Adenylyl cyclases are membrane-associated enzymes of the lyase class that are expressed in most human tissues. These enzymes catalyze the formation of cyclic AMP and pyrophosphate from ATP and are regulated by a family of G protein-coupled receptors, protein kinases, and calcium. Adenylyl cyclase is encoded by the ADCY9 gene and widely distributed. It is stimulated by beta-adrenergic receptor activation but is insensitive to forskolin, calcium, and somatostatin. It may play a fundamental role in situations where fine interplay between intracellular Ca(2+) and cAMP determines the cellular function. It also may be a physiologically relevant docking site for calcineurin. ( NCI )] (UMLS (NCI) C1382029) Adenyl Cyclase 9;
Adenylate Cyclase;
Adenylyl Cyclase 9;
Adenylylcyclase 9;
ATP Pyrophosphate-Lyase;
EC 4.6.1.1 =Amino Acid, Peptide, or Protein; Enzyme |
- 11. A Disintegrin and Metalloproteinase Domain 11 Protein
- [This protein is a member of the ADAM protein family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The gene represents a candidate tumor supressor gene for human breast cancer based on its location within a minimal region of chromosome 17q21 previously defined by tumor deletion mapping. (LocusLink) ( NCI )] (UMLS (NCI) C1332016) ADAM11;
ADAM11 Protein;
Metalloproteinase-Like, Disintegrin-Like and Cysteine-Rich Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 61. ADD
- (UMLS (HL7) C1548443) =Intellectual Product =Problem/goal action code;
|
- 12. A Disintegrin and Metalloproteinase Domain 15
- [MDC-15; ADAM-15; metargidin. Member of a sequence-related family of cysteine-rich membrane proteins containing metalloproteinase-like and disintegrin-like domains; contains an RGD sequence in its disintegrin domain. ( NCI )] (UMLS (NCI) C1313290) ADAM15;
EC 3.4.24.-;
MDC15;
Metalloprotease-RGD-Disintegrin Protein;
Metalloproteinase-Like Disintegrin-Like and Cysteine-Rich Protein 15;
Metargidin =Amino Acid, Peptide, or Protein; Enzyme ;
| - 62. Add ordered tests to the existing specimen
- (UMLS (HL7) C1546519) =Intellectual Product =Specimen Action Code;
|
- 13. A Disintegrin and Metalloproteinase Domain 15 Gene
- [This gene is involved in the restructuring of the mesangial matrix. ( NCI )] (UMLS (NCI) C1332017) ADAM15;
ADAM15 Gene;
=Gene or Genome ;
| - 63. Add personnel record
- (UMLS (HL7) C1548071) =Idea or Concept =Message type;
|
- 14. A Disintegrin and Metalloproteinase Domain 17 (Tumor Necrosis Factor, Alpha, Converting Enzyme) Gene
- [This gene plays a role in the cleavage of membrane proteins, resulting in the release of their extracellular domains from cells. ( NCI )] (UMLS (NCI) C1412186) ADAM17;
ADAM17 Gene =Gene or Genome ;
| - 64. Add record to master file
- (UMLS (HL7) C1549606) =Intellectual Product =Record-level event code;
|
- 15. A Disintegrin-Like and Metalloprotease (Reprolysin Type) with Thrombospondin Type 1 Motif, 1 Gene
- [This gene is involved in the inhibition of angiogenesis and cell proliferation. ( NCI )] (UMLS (NCI) C1332018) ADAMTS1;
ADAMTS1 Gene;
=Gene or Genome ;
| - 65. ADD-Type Zinc-Finger
- (UMLS (NCI) C1510685) =Amino Acid Sequence ;
|
- 16. A Disintegrin-Like and Metalloprotease (Reprolysin Type) with Thrombospondin Type 1 Motif, 9 Gene
- [This gene plays a role in apoptosis and development. ( NCI )] (UMLS (NCI) C1332020) ADAMTS9;
ADAMTS9 Gene;
=Gene or Genome ;
| - 66. Add/change billing account
- (UMLS (HL7) C1548013) =Idea or Concept =Message type;
|
- 17. A-DNA
- [A-DNA is a shorter and wider helix than B-DNA. Most RNA and RNA-DNA duplex are in this form. While deep, narrow major groove is not easily accessible to proteins but wide, shallow minor groove is accessible to proteins but with lower information content than major groove. A-DNA is the favored conformation at low water concentrations. Base pairs are tilted to helix axis and displaced from axis and sugar pucker is C3'-endo (in RNA 2'-OH inhibits C2'-endo conformation). When examined from the top of the helix, there is a large hole in the middle, the sugar phosphate backbone is at the edge of the helix, and the bases are displaced towards the edge. ( NCI )] (UMLS (NCI) C0000702) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
| - 67. Add/Insert
- (UMLS (HL7) C1548565) =Intellectual Product =Action Code;
◊ (UMLS (HL7) C1549771) Intellectual Product Segment action code; |
- 18. AD
- [neurodegenerative disorder of the CNS resulting in progressive loss of memory and intellectual functions; begins in the middle or later years; characterized by brain lesions such as neurofibrillary tangles and neuritic plaques. ( CSP )] (UMLS (CSP) C0002395) =Disease or Syndrome
| - 68. Added Concurrent Therapy
- [Instituted an additional therapy to mitigate potential negative effects ( HL7V3.0 )] (UMLS (HL7) C1555298) =Intellectual Product =Other Action Taken;
|
- 19. AD
- [A country in Southwestern Europe, between France and Spain. (NCI) ( NCI )] (UMLS (NCI) C0002838) =Geographic Area
| - 69. Addendum
- [An appendage to an existing document that contains supplemental information. The parent document remains content is unaltered. ( NCI )] (UMLS (NCI) C1510776) =Intellectual Product
|
- 20. Ad
- (UMLS (NCI) C0547043) =Spatial Concept
| - 70. Adderall
- (UMLS (NCI) C0290795) =Organic Chemical; Pharmacologic Substance ;
|
- 21. AD 32
- [An anticancer drug that belongs to a family of drugs called antitumor antibiotics. It is an anthracycline. ( NCI )] (UMLS (NCI) C0101466) =Organic Chemical; Antibiotic ;
| - 71. Adderall XR
- (UMLS (NCI) C1170024) Adderall-XR =Organic Chemical; Pharmacologic Substance ;
|
- 22. Ad 5-TNF Alpha
- [A recombinant agent consisting of a genetically-modified adenovirus 5 vector encoding the protein cytokine tumor necrosis factor (TNF) alpha. TNF exhibits potent anti-tumor cytolytic properties; the adenovirus 5 vector efficiently infects tumor cells, delivering tumor-specific TNF. (NCI04) ( NCI )] (UMLS (NCI) C1327819) Adenovirus 5-Tumor Necrosis Factor Alpha =Pharmacologic Substance; Immunologic Factor
| - 72. ADDH
- [A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV) ( MSH )] (UMLS (CSP) C1263846) ADHD;
ADHD (attention deficit hyperactivity disorder);
Attention deficit disorder of childhood with hyperactivity;
Attention Deficit Disorder with Hyperactivity;
attention deficit hyperactivity disorder;
ATTN DEFICIT W HYPERACT;
HYPERKINETIC SYND NOS;
Hyperkinetic syndrome of childhood;
Unspecified hyperkinetic syndrome of childhood =Mental or Behavioral Dysfunction =Attention Deficit and Disruptive Behavior Disorders;
|
- 23. Ad CMV I kappaB alpha
- (UMLS (NCI) C1510775) =Pharmacologic Substance
| - 73. addiction
- [Uncontrollable craving, seeking, and use of a substance such as a drug or alcohol. ( NCI )] (UMLS (NCI) C0085281) =Mental or Behavioral Dysfunction
|
- 24. Ad-CD154
- [An adenovirus vector engineered to produce CD40 ligand. For use as a possible gene therapy agent. May induce apoptosis through the TNF pathway. ( NCI )] (UMLS (NCI) C0796342) Ad-CD40 Ligand;
Ad-CD40L;
Adenovirus 5-CD40 Ligand;
=Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 74. Addiction (Substance Use Disorder)
- (UMLS (HL7) C1555895) =Intellectual Product =Counselor;
◊ (UMLS (HL7) C1555901) Intellectual Product Psychologist; ◊ (UMLS (HL7) C1555965) Intellectual Product Registered Nurse; |
- 25. AD-CD40-L/IL-2
- (UMLS (NCI) C0796343) Adenovirus 5-CD40-L Vector/Interleukin-2;
=Therapeutic or Preventive Procedure | - 75. Addiction Medicine
- (UMLS (HL7) C1555726) =Intellectual Product =Anesthesiology;
◊ (UMLS (HL7) C1555744) Intellectual Product Family Practice; ◊ (UMLS (HL7) C1555751) Intellectual Product Internal Medicine; ◊ (UMLS (HL7) C1555861) Intellectual Product Psychiatry & Neurology; |
- 26. Ad/L523S
- [A replication-defective adenoviral vaccine harboring the gene encoding human L523S protein, a RNA-binding protein, belongs to the KOC (K homology domain containing protein over-expressed in cancer) family. L523S is normally expressed in early embryonic tissues. However, L523S also was overexpressed in, but not limited to, squamous cell cancers of the lung. Upon transfection, recombinant adenovirus-L523S expresses human L523S, which may stimulate a cytotoxic T-cell (CTL) response against tumor cells expressing L523S. ( NCI )] (UMLS (NCI) C1328161) Recombinant Adenovirus-L523S Vaccine =Pharmacologic Substance; Immunologic Factor ;
| - 76. Addiction Psychiatry
- (UMLS (HL7) C1555862) =Intellectual Product =Psychiatry & Neurology;
|
- 27. Ad5-bFGF
- (UMLS (NCI) C1510799) Adenovirus 5-Fibroblast Growth Factor 2;
Adenovirus Serotype 5 Expressing bFGF =Pharmacologic Substance; Immunologic Factor | - 77. Addison's disease
- [disease characterized by hypotension, weight loss, anorexia, weakness, and sometimes a bronze-like melanotic hyperpigmentation of the skin; due to tuberculosis or autoimmune induced disease (hypofunction) of the adrenal glands that results in deficiency of aldosterone and cortisol. ( CSP )] (UMLS (CSP) C0001403) =Disease or Syndrome
|
- 28. Ad5CMV
- [A recombinant replication-deficient serotype 5 adenovirus. Containing an expression cassette consisting of the human cytomegalovirus (CMV) promoter and the simian virus 40 (SV40) polyadenylation signal, Ad5CMV is used as a transfer vector for inserting genes of interest into target cells for expression. (NCI04) ( NCI )] (UMLS (NCI) C1510774) =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 78. Additional information
- (UMLS (HL7) C1546922) =Temporal Concept =Report timing;
|
- 29. Ad5CMV p53 Gene
- [A replication-defective adenoviral-CMV vector that encodes a wild-type p53 gene. Ad5CMV-p53 induces tumor cells that have been transfected with the vector to produce wild-type p53, a tumor suppressor gene that is deleted or mutated in a significant number of cancers. In transfected tumor cells, the wild-type p-53 gene product exerts an antitumor effect by blocking cell cycle progression at the G1/S regulation point, activating DNA repair proteins in the presence of DNA damage, and initiating apoptosis when DNA damage is irreparable. (NCI04) ( NCI )] (UMLS (NCI) C0678021) =Pharmacologic Substance
| - 79. additional locator
- [This can be a unit designator, such as apartment number, suite number, or floor. There may be several unit designators in an address (e.g., "3rd floor, Appt. 342"). This can also be a designator pointing away from the location, rather than specifying a smaller location within some larger one (e.g., Dutch "t.o." means "opposite to" for house boats located across the street facing houses). ( HL7V3.0 )] (UMLS (HL7) C1550716) =Idea or Concept =AddressPartType;
=unit designator;
unit identifier;
|
- 30. Ad5CMV-p53 gene/Cisplatin/Fluorouracil
- (UMLS (NCI) C1134689) =Therapeutic or Preventive Procedure
| - 80. Additional payment for service not provided by Medicare
- (UMLS (HL7) C1547455) =Intellectual Product =OCE Edit Code;
|
- 31. Ad5CMV-p53 gene/Docetaxel
- (UMLS (NCI) C1134690) =Therapeutic or Preventive Procedure
| - 81. Additional tissue required
- (UMLS (HL7) C1547221) =Intellectual Product =Tissue Type Code;
|
- 32. Ad5CMV-p53 Gene/Docetaxel/Doxorubicin
- (UMLS (NCI) C1327753) =Therapeutic or Preventive Procedure ;
| - 82. Additional X Chromosome
- (UMLS (NCI) C1510777) =Cell or Molecular Dysfunction
|
- 33. ADA
- [Adenosine deaminase catalyzes the hydrolysis of adenosine to inosine. ADA deficiency causes one form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins. (LocusLink) ( NCI )] (UMLS (NCI) C0001457) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 83. Additive
- (UMLS (HL7) C1549547) =Idea or Concept =RX Component Type;
|
- 34. ADA
- [This gene is involved in nucleotide metabolism and cellular immunity. ( NCI )] (UMLS (NCI) C1412179) ADA Gene;
Adenosine Deaminase Gene =Gene or Genome ;
| - 84. additive
- [A substance that is added to a system or compound to improve its characteristics. ( NCI )] (UMLS (HL7) C1550602) =Substance =ingredient;
|
- 35. ADA Inhibitor
- [Substances that inhibit Adenosine Deaminase, an enzyme involved with purine metabolism. ( NCI )] (UMLS (NCI) C1373051) Adenosine Deaminase Inhibitor;
Adenosine Deaminase Inhibitors;
=Pharmacologic Substance ;
=Inhibitors, Nucleic Acid Synthesis;
| - 85. additive, non-propagating
- [The association adds to the existing context associated with the Act, but will not propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Non-Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts for the purpose of this Act. However only the previously propagated authors will propagate to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552005) =Idea or Concept =ContextControlAdditive;
ContextControlNonPropagating |
- 36. ADA Transduced T Cell
- [T cells harvested from a patient with adenosine deaminase (ADA) deficiency and transduced with a vector containing the gene for ADA. ADA catalyzes the hydrolysis of adenosine to inosine; ADA deficiency causes a form of severe combined immunodeficiency (SCID). Following genetic modification, the T cells are returned to the patient, where they produce functional ADA. ADA-transduced T cells have been shown to improve immune function in individuals with ADA deficiency. (NCI04) ( NCI )] (UMLS (NCI) C1510684) =Cell ;
| - 86. additive, propagating
- [The association adds to the existing context associated with the Act, and will propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts, and will itself propagate with the other authors to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552003) =Idea or Concept =ContextControlAdditive;
ContextControlPropagating |
- 37. Adalat
- (UMLS (NCI) C0590658) =Organic Chemical; Pharmacologic Substance
| - 87. Additive/Preservative
- (UMLS (HL7) C1547765) =Biomedical or Dental Material =HL7 Vocabulary Version 2.5;
=ACETIC ACID;
Polydesis;
Potassium/K EDTA;
Potassium Oxalate;
FLUORIDE (AS SODIUM FLUORIDE);
HEPARIN SODIUM;
fibrinogenase;
Thymol;
toluene;
Bouin's solution;
nitric acid;
Phenol;
ACD Solution A;
Sodium Fluoride 10 MG;
ACD Solution B;
Amies transport medium;
Bacterial Transport medium;
Buffered 10% formalin;
Borate Boric Acid;
Buffered skim milk;
3.2% Citrate;
3.8% Citrate;
Carson's Modified 10% formalin;
Cary Blair Medium;
Chlamydia transport medium;
CTAD (this should be spelled out if not universally understood);
Potassium/K EDTA 15%;
Potassium/K EDTA 7.5%;
Sodium/Na EDTA;
Enteric bacteria transport medium;
Enteric plus;
10% Formalin;
"Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products)"
;Sodium Fluoride, 100mg;
6N HCL;
Ammonium heparin;
Lithium/Li Heparin;
Jones Kendrick Medium;
Karnovsky's fixative;
Lithium iodoacetate;
M4;
M4-RT;
M5;
Michel's transport medium;
MMD transport medium;
Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride;
Pages's Saline;
Reagan Lowe Medium;
Siliceous earth, 12 mg;
SPS(this should be spelled out if not universally understood);
Serum Separator Tube (Polymer Gel);
Stuart transport medium;
Thyoglycollate broth;
Ureaplasma transport medium;
Viral Transport medium;
Buffered Citrate (Westergren Sedimentation Rate);
None |
- 38. ADAM Family Gene
- [ADAMs (A Disintegrin and Metalloproteinase Domain) are membrane-anchored proteases that regulate cell behavior by proteolytically modifying the cell surface and extracellular matrix. Currently, the ADAM family has 29 members, although the function of most ADAM gene products is unknown. The ADAM gene products with known functions act in a highly diverse set of biological processes, including fertilization, neurogenesis, myogenesis, embryonic TGF-alpha release and the inflammatory response. (from J Cell Biol 2002;159:893-902 and NCI) ( NCI )] (UMLS (NCI) C1332022) =Gene or Genome ;
| - 88. Address
- (UMLS (HL7) C1547327) =Intellectual Product =Value type;
|
- 39. ADAM Family Protein
- [The ADAM family consists of transmembrane proteins that contain a disintegrin and metalloprotease domain. By virtue of these domains they have the potent for both cell adhesion and protease activities. Currently, the ADAM family has 29 membranes, although the function of most ADAM gene products is unknown. The ADAM gene products with known functions act in a highly diverse set of biological processes, including fertilization, neurogenesis, myogenesis, embryonic TGF-alpha release and the inflammatory response. ( NCI )] (UMLS (NCI) C1332023) =Amino Acid, Peptide, or Protein; Enzyme
| - 89. Address
- (UMLS (HL7) C1578437) =Intellectual Product =Data type;
|
- 40. ADAM Type Metalloprotease Domain
- [ADAMs are transmembrane proteins containing both a disintegrin and a metalloprotease domain. Two thirds of the proteins with an ADAM type metalloprotease domain also contain the zinc protease pattern which locates the active site of these proteases. As they contain an adhesion domain and a protease domain, ADAM proteins potentially have both cell adhesion and protease activities. They play a role in various biological processes, including fertilization, neurogenesis, myogenesis, embryonic TGF-alpha release and inflammatory response. In ADAMTS proteins, a closely related family of proteases, the metalloprotease and disintegrin domains are flanked by thrombospondin type I (TSP1) repeat. ADAMTS proteins are soluble, extracellular matrix proteases. (From InterPro IPR001590) ( NCI )] (UMLS (NCI) C1510683) =Amino Acid Sequence ;
| - 90. Address
- [For attributes representing the location at which an organization, person, or item may be found or reached. ( HL7V3.0 )] (UMLS (HL7) C1578436) =Intellectual Product =MDFAttributeType;
|
- 41. adamantane
- [A tricyclo bridged hydrocarbon. ( MSH )] (UMLS (CSP) C0001392) =Organic Chemical
| - 91. Address Part
- (UMLS (HL7) C1552678) =Idea or Concept =Character;
|
- 42. Adamantinoid Basal Cell Carcinoma
- (UMLS (NCI) C1304295) Skin Adamantinoid Basal Cell Carcinoma;
Skin Adamantinoid Basal Cell Epithelioma;
=Neoplastic Process | - 92. Address type
- (UMLS (HL7) C1547607) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Firm/Business;
Bad address;
Birth delivery location (address where birth occurred);
Residence at birth (home address at time of birth);
Current Or Temporary;
Country Of Origin;
Home;
Legal Address;
Mailing;
Birth (nee) (birth address, not otherwise specified);
Office;
Permanent;
Registry home. Refers to the information system, typically managed by a public health agency, that stores patient information such as immunization histories or cancer data, regardless of where the patient obtains services. |
- 43. Adamantinoma
- [A locally aggressive, osteolytic neoplasm of the long bones, probably of epithelial origin and most often involving the TIBIA. ( MSH )] (UMLS (NCI) C1367554) =Neoplastic Process
| - 93. AddressPartType
- [Discussion: The hierarchical nature of these concepts shows composition. E.g. "Street Name" is part of "Street Address Line" ( HL7V3.0 )] (UMLS (HL7) C1553795) =Intellectual Product =CodeSystem;
=postal code;
country;
state or province;
municipality;
additional locator;
county or parish;
street address line;
care of;
precinct;
building number suffix;
delivery address line;
census tract;
delimiter;
|
- 44. Adamantinoma of Long Bones
- (UMLS (NCI) C0334556) =Neoplastic Process
| - 94. AddressUse
- (UMLS (HL7) C1698330) =Spatial Concept ;
=PostalAddressUse;
=job site;
home address;
temporary address;
birthplace |
- 45. Adamantinomatous Craniopharyngioma
- [A craniopharyngioma consisting of broad strands, cords and bridges of a multistratified squamous epithelium with peripheral palisading of nuclei. Diagnostic features include nodules of compact 'wet' keratin and dystrophic calcification. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0431129) =Neoplastic Process ;
| - 95. adduct
- [compound produced by the mixing of two or more chemicals or a complex that forms when a chemical binds to a biological molecule, such as DNA or a protein. ( CSP )] (UMLS (CSP) C0596040) =Chemical Viewed Structurally ;
=chemical bond;
|
- 46. Adams Laboratories
- [Adams Laboratories ( HL7V3.0 )] (UMLS (HL7) C1552882) =Health Care Related Organization =VaccineManufacturer;
| - 96. ADDUCTOR TENOTOMY OF HIP
- [ ] (UMLS (ICD9CM) C0407093) =Therapeutic or Preventive Procedure
|
- 47. Adams Laboratories, Inc.
- (UMLS (HL7) C1546859) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
| - 97. ADE
- (UMLS (NCI) C0057163) =Therapeutic or Preventive Procedure
|
- 48. ADAMTS
- [ ] (UMLS (CSP) C1328825) =Amino Acid, Peptide, or Protein; Enzyme
| - 98. AdEERS
- [A Web application developed for the electronic submission of Expedited Reports to the NCI for serious and/or unexpected Adverse Events, deaths, and other events defined in the NCI Guidelines: Adverse Event Reporting Requirements for NCI Investigational Agents ( NCI )] (UMLS (NCI) C1510820) Adverse Drug Experience Reporting System;
Adverse Event Expedited Reporting System =Intellectual Product |
- 49. Adanon
- (UMLS (NCI) C0699058) =Organic Chemical; Pharmacologic Substance
| - 99. Adefovir Dipivoxil
- [An acyclic nucleotide adenine analogue with potent antiviral activity. Adefovir is activated in vivo to a diphosphate metabolite which is incorporated into viral DNA, leading to viral RNA-dependent DNA polymerase inhibition, DNA chain termination and impairment of viral replication. This agent inhibits the reverse transcriptases of hepatitis B, herpes and HIV viruses, induces natural killer cell activity, and stimulates endogenous interferon production. Viral resistance to adefovir develops at a slower rate compared to other antivirals. (NCI04) ( NCI )] (UMLS (NCI) C0540694) =Organic Chemical; Pharmacologic Substance ;
=9-(2-phophonylmethoxyethyl)adenine;
Unclassified Ingredients =ADEFOVIR DIPIVOXIL 10 MG |
- 50. Adapter Molecule CRK
- [Containing SH2 and SH3 homology domains that interact with ABL, the tumor suppressor CRK protein appears to be a protein involved in signal transduction. (from OMIM 164762 and NCI) ( NCI )] (UMLS (NCI) C1451465) CRK;
CRK Protein;
P38;
Proto-Oncogene c-CRK =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 100. Adelaide River virus
- [ ] (UMLS (CSP) C0599348) =Virus ;
|
home
